1. Home
  2. LZM vs FBRX Comparison

LZM vs FBRX Comparison

Compare LZM & FBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lifezone Metals Limited

LZM

Lifezone Metals Limited

HOLD

Current Price

$3.62

Market Cap

385.4M

ML Signal

HOLD

Logo Forte Biosciences Inc.

FBRX

Forte Biosciences Inc.

HOLD

Current Price

$24.55

Market Cap

379.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LZM
FBRX
Founded
2021
N/A
Country
Isle of Man
United States
Employees
142
N/A
Industry
Metal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
385.4M
379.3M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
LZM
FBRX
Price
$3.62
$24.55
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$7.00
$67.00
AVG Volume (30 Days)
185.7K
170.7K
Earning Date
03-19-2026
03-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$36,000.00
Revenue This Year
$510.94
N/A
Revenue Next Year
$217.65
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.90
$4.91
52 Week High
$6.23
$35.62

Technical Indicators

Market Signals
Indicator
LZM
FBRX
Relative Strength Index (RSI) 31.49 34.47
Support Level N/A $9.76
Resistance Level $4.61 $32.40
Average True Range (ATR) 0.26 2.22
MACD -0.05 -0.53
Stochastic Oscillator 5.98 8.56

Price Performance

Historical Comparison
LZM
FBRX

About LZM Lifezone Metals Limited

Lifezone Metals Ltd seeks to support the clean energy transition through the licensing of Hydromet Technology as an alternative to smelting and metals refining and to become an emerging supplier of responsibly sourced, lower-carbon and lower-sulfur dioxide emission metals to the battery, EV, and hydrogen markets modern pre-development exploration-stage metals company. Its business comprises three segments: Metals extraction and refining for developing and operating a vertically integrated base metal operation in the northwest region of Tanzania and Intellectual property licensing comprises patents residing with and managed by the subsidiary and corporate.

About FBRX Forte Biosciences Inc.

Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).

Share on Social Networks: